STEM-Talk cover image

Episode 127: From UFOs to fasting to the keto flu, Ken & Dawn answer questions

STEM-Talk

CHAPTER

Is the FDA Approval of Aduhelm a Sign of All Simmers Disease?

The f d as recently approved it for the treatment of alsimers disease. The drug costs roughly 56 thousand dollars per year, and patients must receive monthly infusions. About forty % of the trial participants develop brain bleeding or brain swelling. Two major health systems decidet they will not administer this drug to patients in new york city.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner